📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial (2021)

First Author: Van Santen D

Attributed to: The MRC Addiction Research Clinical Training programme: MARC funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/add.15503

PubMed Identifier: 33788326

Publication URI: http://europepmc.org/abstract/MED/33788326

Type: Journal Article/Review

Parent Publication: Addiction

Issue: 11

ISSN: 0965-2140